Arimidex
Arimidex is developed to target hormone-dependent breast cancer and is formulated to alleviate tumour progression.
- Categories
- Women's Health · Oncology Support · Pct & Men's Fitness
- Active ingredient
- Anastrozole
- Supply
- Rx
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 1mg
Arimidex details
- Condition
- Breast Cancer
- Therapeutic class
- Aromatase Inhibitor
- Pharmacological class
- Aromatase Inhibitor
- Known off-label uses
- infertility
- Contraindications
- hypersensitivity to anastrozole; pre-menopausal women; pregnancy; breastfeeding
- Minor side effects
- hot flushes; asthenia; arthralgia; headache
- Moderate side effects
- vaginal dryness; hair thinning; nausea; rash
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- AstraZeneca
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store at room temperature below 30°C.
- Drug interactions
- Oestrogen containing therapies; Tamoxifen
- Age restrictions
- Indicated strictly for post-menopausal women.
- Pregnancy and breastfeeding
- Pregnancy: Contraindicated. Breastfeeding: Contraindicated.
Precautions and warnings
assess bone mineral density regularly; monitor lipid profile; use with caution in moderate to severe hepatic impairment
Serious side effects
osteoporosis, requires immediate medical attention; bone fractures, requires immediate medical attention; severe skin reactions, requires immediate medical attention
Patient summary
Arimidex is developed to target hormone-dependent breast cancer and is formulated to alleviate tumour progression.
Mechanism of action
This medicine acts as a potent and selective non-steroidal aromatase inhibitor. It lowers circulating oestrogen levels in post-menopausal women by blocking the enzyme responsible for the peripheral conversion of androgens into oestrogens, thereby limiting the growth of hormone-sensitive tumours.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Arimidex
Arimidex is the primary brand name for anastrozole, a medication used in the treatment of breast cancer. Manufactured by AstraZeneca, this therapy is supplied as a 1mg tablet. By reducing the concentration of the hormone oestrogen, it supports specific hormonal management protocols in patients diagnosed with this condition.
Arimidex availability in Asia
Arimidex is registered across 14 markets including Japan, the UAE and Singapore, with availability also in Hong Kong, Thailand and Malaysia. Generic anastrozole, much of it made in India, is far more affordable than the original brand, providing an important access point for expats living in regions with limited stock. This medication is intended for use under a doctor’s care to ensure the correct maintenance of hormone levels.